Rivastigmine modestly improves dementia associated with Parkinson's disease, but has important adverse effects
- PMID: 15851804
- DOI: 10.1136/ebmh.8.2.41
Rivastigmine modestly improves dementia associated with Parkinson's disease, but has important adverse effects
Comment on
-
Rivastigmine for dementia associated with Parkinson's disease.N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470. N Engl J Med. 2004. PMID: 15590953 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources